Triple Therapy Shows Edge in Lung Cancer Lacking Targetable Mutations
A new network meta-analysis of five trials involving 2,452 patients finds that triple therapy combining immunotherapy, antiangiogenic antibodies, and chemotherapy ...
A new network meta-analysis of five trials involving 2,452 patients finds that triple therapy combining immunotherapy, antiangiogenic antibodies, and chemotherapy ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine